Brain inflammation is unlikely to explain persistent long COVID symptoms, neuroimaging study finds
· Medical Xpressedited by Lisa Lock, reviewed by Robert Egan
Lisa Lock
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Associate Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
A new brain imaging study has found no evidence of widespread brain inflammation in patients suffering from prolonged symptoms after COVID-19 infection. Instead, the most severe long COVID symptoms were associated with increased brain activity in regions involved in mood and emotion. The study is published in the Journal of Neurology.
Long COVID has been suspected to involve persistent brain inflammation following SARS-CoV-2 infection, potentially explaining symptoms such as fatigue, cognitive impairment, anxiety, and depression. While previous studies have suggested this possibility, direct evidence has been limited.
Researchers at the University of Turku, Finland, used advanced brain imaging techniques to investigate whether long COVID patients with persistent symptoms show signs of brain inflammation.
"We did not observe evidence of widespread brain inflammation in patients with long COVID when compared to healthy controls," says Professor of Neuroimmunology and InFLAMES Research Flagship group leader Laura Airas, who led the study.
The study included 14 individuals with long COVID, 11 healthy controls, and 13 patients with multiple sclerosis (MS), a neurological disease known to involve brain inflammation.
All participants underwent PET imaging sensitive to neuroinflammation, along with magnetic resonance imaging (MRI) to assess brain structure and white matter changes. Blood samples were analyzed for biomarkers reflecting neuronal and glial damage.
Compared to MS patients, individuals with long COVID showed significantly lower inflammatory activity in the brain's white matter. No differences in markers of brain inflammation or neurodegeneration were observed between long COVID patients and healthy controls.
Brain inflammation may be present early after infection
Clear signs of brain inflammation have previously been observed in neuropathological studies of severe acute COVID-19. In the current study, individuals scanned within 16 months of infection showed higher white matter inflammatory activity compared to those with longer disease duration.
According to Airas, this suggests that inflammation may be more prominent during the early phase of the disease and decrease over time.
An important finding of the study was that higher levels of depression and anxiety, as well as lower quality of life, were associated with increased cellular activity in the hippocampus and amygdala. They are brain regions involved in memory, emotional regulation, and stress responses.
These findings suggest that altered cellular activation in emotion-regulating brain regions may be linked to symptom severity in some patients with long COVID.
Toward a clearer understanding of long COVID and targeted treatments
The researchers note that the findings refine our understanding of long COVID and challenge the idea that persistent brain inflammation is the primary driver of prolonged symptoms in all patients. Instead, the results point to a more complex disease profile, where inflammatory changes may be strongest right after infection and diminish over time.
Long COVID is a recognized condition affecting millions of people worldwide, with symptoms that can persist for months or even years after the initial infection.
The researchers suggest that patients with prolonged symptoms may benefit more from treatments targeting stress and emotional regulation rather than therapies aimed solely at reducing inflammation.
"This study highlights the need to continue investigating the complex biological mechanisms underlying long COVID. Understanding these processes is essential for developing targeted treatments," notes Airas.
Publication details
Joel Tuomaala et al, Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study, Journal of Neurology (2026). DOI: 10.1007/s00415-026-13842-w
Journal information: Journal of Neurology
Key medical concepts
NeuroinflammationsPost-Acute COVID-19 SyndromePositron-Emission TomographyMagnetic Resonance ImagingHippocampus
Clinical categories
NeurologyInfectious diseasesCommon illnesses & PreventionPsychiatry Provided by University of Turku Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Brain inflammation is unlikely to explain persistent long COVID symptoms, neuroimaging study finds (2026, May 22) retrieved 22 May 2026 from https://medicalxpress.com/news/2026-05-brain-inflammation-persistent-covid-symptoms.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.